Eliminating
false positives or negatives in analysis has been a
challenge. Herein, a phenomenon of polarity-switching photocurrent
of AgInS2 quantum dot (QD)–DNA nanowires reversing
nitrogen-doped porous carbon–ZnO (NPC–ZnO) nanopolyhedra
was found for the first time, and a versatile photoelectrochemical
(PEC) biosensor with a reversed signal was innovatively proposed for
dual-target detection. NPC–ZnO is a photoactive material with
excellent PEC properties, while AgInS2 QDs as a photosensitive
material match NPC–ZnO in the energy level, which not only
promotes the transfer of photogenerated carriers but also switches
the direction of PEC current. Furthermore, in order to prevent spontaneous
agglomeration of AgInS2 (AIS) QDs and improve its utilization
rate, a new multiple-branched DNA nanowire was specially designed
to assemble AgInS2 QDs for constructing amplified signal
probes, which not only greatly increased the load of AgInS2 QDs but also further enhanced the photoelectric signal. When the
target Hg2+-induced cyclic amplification process generated
abundant RDNA, the DNA nanowire signal probe with plenty of QDs was
linked to the NPC–ZnO/electrode by RDNA, generating greatly
amplified polarity-reversed photocurrent for signal “ON”
detection of Hg2+. After specific binding of the target
(aflatoxin B1, AFB1) to its aptamer, the signal probes of AIS QD-DNA
nanowires were released, realizing signal “OFF” assay
of AFB1. Thus, the proposed new PEC biosensor provides a versatile
method for detection of dual targets and also effectively avoids both
false positive and negative phenomena in the assay process, which
has great practical application potential in both environmental and
food analysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.